Companies / BOC Sciences / Inebilizumab
BOC Sciences

Inebilizumab | BOC Sciences

Inebilizumab is an anti-CD19 monoclonal antibody used to treat adults with neuromyelitis optica spectrum disorders (NMOSD).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
  • See More